8
1 An Experimental Vaccine Against Aeromonas hydrophila can Induce Protection in Rainbow trout Scott E. LaPatra Clear Springs Foods, Inc., Buhl, Idaho, U.S.A. Acknowledgements Karen Plant Bill Shewmaker Robin Burkhart Merle Higgins Andy Morton

An Experimental Vaccine Against Aeromonas hydrophila can

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: An Experimental Vaccine Against Aeromonas hydrophila can

1

An Experimental Vaccine Against Aeromonas hydrophila can Induce Protection

in Rainbow trout Scott E. LaPatra Clear Springs Foods, Inc., Buhl,

Idaho, U.S.A.

Acknowledgements

!   Karen Plant !   Bill Shewmaker !   Robin Burkhart !   Merle Higgins !   Andy Morton

Page 2: An Experimental Vaccine Against Aeromonas hydrophila can

2

Page 3: An Experimental Vaccine Against Aeromonas hydrophila can

3

Page 4: An Experimental Vaccine Against Aeromonas hydrophila can

4

Aeromonas hydrophila Vaccine Development

!   Formalin killed, toxoid and live

attenuated

!   Inject (adjuvant) vs bath

!   Immunogenicity and delivery

potential of a lysate

!   Development of a model system

Page 5: An Experimental Vaccine Against Aeromonas hydrophila can

5

Challenge Model Development Intraperitoneal Injection (IP)

Challenge Model Development Dorsal Sinus Injection (DS)

Page 6: An Experimental Vaccine Against Aeromonas hydrophila can

6

Challenge Model Development Lethal Dose 50% Determination

Susceptibility of Survivors Primary Challenge

!   Triplicate 25-fish groups (mw, 7 g)

!   100 ul, 10(-1) thru 10(-4), 1.0 OD

!   16% cumulative mortality at

highest challenge dose

!   No mortality at other doses

Page 7: An Experimental Vaccine Against Aeromonas hydrophila can

7

Susceptibility of Survivors Re-challenge, 10 g fish

Passive Immunization IP Delivery, 2 g fish

Page 8: An Experimental Vaccine Against Aeromonas hydrophila can

8

Vaccine Trial 4 wpv / 420 dd / 8 g

Aeromonas hydrophila Vaccine Development

!   DS vs IP challenge procedure

!   Effect of washing cells

!   LD(50) determination

!   Susceptibility of survivors

!   Passive immunization

!   Preliminary vaccine evaluation